» Articles » PMID: 28051183

HIV-1 Env Associates with HLA-C Free-chains at the Cell Membrane Modulating Viral Infectivity

Abstract

HLA-C has been demonstrated to associate with HIV-1 envelope glycoprotein (Env). Virions lacking HLA-C have reduced infectivity and increased susceptibility to neutralizing antibodies. Like all others MHC-I molecules, HLA-C requires β-microglobulin (βm) for appropriate folding and expression on the cell membrane but this association is weaker, thus generating HLA-C free-chains on the cell surface. In this study, we deepen the understanding of HLA-C and Env association by showing that HIV-1 specifically increases the amount of HLA-C free chains, not bound to βm, on the membrane of infected cells. The association between Env and HLA-C takes place at the cell membrane requiring βm to occur. We report that the enhanced infectivity conferred to HIV-1 by HLA-C specifically involves HLA-C free chain molecules that have been correctly assembled with βm. HIV-1 Env-pseudotyped viruses produced in the absence of βm are less infectious than those produced in the presence of βm. We hypothesize that the conformation and surface expression of HLA-C molecules could be a discriminant for the association with Env. Binding stability to βm may confer to HLA-C the ability to preferentially act either as a conventional immune-competent molecule or as an accessory molecule involved in HIV-1 infectivity.

Citing Articles

Antigen-antibody complex density and antibody-induced HLA protein unfolding influence Fc-mediated antibody effector function.

Murali T, Gu Y, Minhat R, Yap J, Wood K, Wang C Front Immunol. 2025; 15:1438285.

PMID: 39744638 PMC: 11688311. DOI: 10.3389/fimmu.2024.1438285.


The Role of Beta2-Microglobulin in Central Nervous System Disease.

Liu Z, Tang F, Yang J, Chen X, Wang Z, Li Z Cell Mol Neurobiol. 2024; 44(1):46.

PMID: 38743119 PMC: 11093819. DOI: 10.1007/s10571-024-01481-6.


Is the Development of Ascites in Alcoholic Liver Patients Influenced by Specific KIR/HLA Gene Profiles?.

Legaz I, Morales R, Bolarin J, Collados-Ros A, Pons J, Muro M Biomedicines. 2023; 11(9).

PMID: 37760846 PMC: 10525207. DOI: 10.3390/biomedicines11092405.


Increased Prevalence of Unstable HLA-C Variants in HIV-1 Rapid-Progressor Patients.

Stefani C, Sangalli A, Locatelli E, Federico T, Malerba G, Romanelli M Int J Mol Sci. 2022; 23(23).

PMID: 36499177 PMC: 9741376. DOI: 10.3390/ijms232314852.


Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.

Valenzuela-Fernandez A, Cabrera-Rodriguez R, Casado C, Perez-Yanes S, Pernas M, Garcia-Luis J Biomedicines. 2022; 10(9).

PMID: 36140273 PMC: 9495913. DOI: 10.3390/biomedicines10092172.


References
1.
Triantafilou M, Triantafilou K, Wilson K, Takada Y, Fernandez N, Stanway G . Involvement of beta2-microglobulin and integrin alphavbeta3 molecules in the coxsackievirus A9 infectious cycle. J Gen Virol. 1999; 80 ( Pt 10):2591-2600. DOI: 10.1099/0022-1317-80-10-2591. View

2.
Hu C, Kerppola T . Simultaneous visualization of multiple protein interactions in living cells using multicolor fluorescence complementation analysis. Nat Biotechnol. 2003; 21(5):539-45. PMC: 1820765. DOI: 10.1038/nbt816. View

3.
Biswas P, Smith C, Goletti D, Hardy E, Jackson R, Fauci A . Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity. 1995; 2(6):587-96. DOI: 10.1016/1074-7613(95)90003-9. View

4.
Center R, Leapman R, Lebowitz J, Arthur L, Earl P, Moss B . Oligomeric structure of the human immunodeficiency virus type 1 envelope protein on the virion surface. J Virol. 2002; 76(15):7863-7. PMC: 136379. DOI: 10.1128/jvi.76.15.7863-7867.2002. View

5.
Lakhashe S, Thakar M, Bharucha K, Paranjape R . Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies. J Virol. 2007; 82(1):428-34. PMC: 2224394. DOI: 10.1128/JVI.00638-07. View